메뉴 건너뛰기




Volumn 17, Issue 6, 2010, Pages 895-903

Comparison of three anthrax toxin neutralization assays

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ANTHRAX TOXIN; ANTHRAX VACCINE; FC RECEPTOR; NEUTRALIZING ANTIBODY; RECOMBINANT ANTIGEN;

EID: 77953154332     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00513-09     Document Type: Article
Times cited : (25)

References (36)
  • 2
    • 69049106516 scopus 로고    scopus 로고
    • Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody
    • Chen, Z., M. Moayeri, D. Crown, S. Emerson, I. Gorshkova, P. Schuck, S. H. Leppla, and R. H. Purcell. 2009. Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody. Infect. Immun. 77:3902-3908.
    • (2009) Infect. Immun. , vol.77 , pp. 3902-3908
    • Chen, Z.1    Moayeri, M.2    Crown, D.3    Emerson, S.4    Gorshkova, I.5    Schuck, P.6    Leppla, S.H.7    Purcell, R.H.8
  • 4
    • 1642577137 scopus 로고    scopus 로고
    • Cutting edge: Anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide
    • Dang, O., L. Navarro, K. Anderson, and M. David. 2004. Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide. J. Immunol. 172:747-751.
    • (2004) J. Immunol. , vol.172 , pp. 747-751
    • Dang, O.1    Navarro, L.2    Anderson, K.3    David, M.4
  • 6
    • 0037205534 scopus 로고    scopus 로고
    • New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible
    • FDA.
    • FDA. 2002. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Fed. Regist. 67:37988-37998.
    • (2002) Fed. Regist. , vol.67 , pp. 37988-37998
  • 7
    • 77953142964 scopus 로고    scopus 로고
    • Anthrax: Bridging Correlates of Protection in Animals to Immunogenicity in Humans
    • FDA. 2007. Anthrax: Bridging Correlates of Protection in Animals to Immunogenicity in Humans. Transcript of a workshop. http://www.fda.gov/cber/ minutes/workshop-min.htm.
    • (2007) Transcript of a Workshop
  • 8
    • 0035972045 scopus 로고    scopus 로고
    • Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin
    • Fellows, P. F., M. K. Linscott, B. E. Ivins, M. L. Pitt, C. A. Rossi, P. H. Gibbs, and A. M. Friedlander. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241-3247.
    • (2001) Vaccine , vol.19 , pp. 3241-3247
    • Fellows, P.F.1    Linscott, M.K.2    Ivins, B.E.3    Pitt, M.L.4    Rossi, C.A.5    Gibbs, P.H.6    Friedlander, A.M.7
  • 9
    • 33746058634 scopus 로고    scopus 로고
    • Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA 102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial
    • Gorse, G. J., W. Keitel, H. Keyserling, D. N. Taylor, M. Lock, K. Alves, J. Kenner, L. Deans, and M. Gurwith. 2006. Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA 102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial. Vaccine 24:5950-5959.
    • (2006) Vaccine , vol.24 , pp. 5950-5959
    • Gorse, G.J.1    Keitel, W.2    Keyserling, H.3    Taylor, D.N.4    Lock, M.5    Alves, K.6    Kenner, J.7    Deans, L.8    Gurwith, M.9
  • 12
    • 0000947082 scopus 로고
    • Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells
    • Leppla, S. H. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations in eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 79:3162-3166.
    • (1982) Proc. Natl. Acad. Sci. U. S. A. , vol.79 , pp. 3162-3166
    • Leppla, S.H.1
  • 14
    • 34250737810 scopus 로고    scopus 로고
    • New insights into the pathogenesis and treatment of anthrax toxin-induced shock
    • Li, Y., K. Sherer, X. Cui, and P. Q. Eichacker. 2007. New insights into the pathogenesis and treatment of anthrax toxin-induced shock. Expert Opin. Biol. Ther. 7:843-854.
    • (2007) Expert Opin. Biol. Ther. , vol.7 , pp. 843-854
    • Li, Y.1    Sherer, K.2    Cui, X.3    Eichacker, P.Q.4
  • 15
    • 0030785493 scopus 로고    scopus 로고
    • Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs
    • Little, S. F., B. E. Ivins, P. F. Fellows, and A. M. Friedlander. 1997. Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs. Infect. Immun. 65:5171-5175.
    • (1997) Infect. Immun. , vol.65 , pp. 5171-5175
    • Little, S.F.1    Ivins, B.E.2    Fellows, P.F.3    Friedlander, A.M.4
  • 16
    • 0345096575 scopus 로고    scopus 로고
    • Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine
    • Little, S. F., B. E. Ivins, P. F. Fellows, M. L. Pitt, S. L. Norris, and G. P. Andrews. 2004. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22:422-430.
    • (2004) Vaccine , vol.22 , pp. 422-430
    • Little, S.F.1    Ivins, B.E.2    Fellows, P.F.3    Pitt, M.L.4    Norris, S.L.5    Andrews, G.P.6
  • 18
    • 1242351553 scopus 로고    scopus 로고
    • The roles of anthrax toxin in pathogenesis
    • Moayeri, M., and S. H. Leppla. 2004. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 7:19-24.
    • (2004) Curr. Opin. Microbiol. , vol.7 , pp. 19-24
    • Moayeri, M.1    Leppla, S.H.2
  • 19
    • 2542638729 scopus 로고    scopus 로고
    • Enhancement of anthrax lethal toxin cytotoxicity: A subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages
    • Mohamed, N., J. Li, C. S. Ferreira, S. F. Little, A. M. Friedlander, G. L. Spitalny, and L. S. Casey. 2004. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect. Immun. 72:3276-3283.
    • (2004) Infect. Immun. , vol.72 , pp. 3276-3283
    • Mohamed, N.1    Li, J.2    Ferreira, C.S.3    Little, S.F.4    Friedlander, A.M.5    Spitalny, G.L.6    Casey, L.S.7
  • 20
    • 47049128494 scopus 로고    scopus 로고
    • Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species
    • and Participating Laboratories
    • Omland, K. S., A. Brys, D. Lansky, K. Clement, F. Lynn, and Participating Laboratories. 2008. Interlaboratory comparison of results of an anthrax lethal toxin neutralization assay for assessment of functional antibodies in multiple species. Clin. Vaccine Immunol. 15:946-953.
    • (2008) Clin. Vaccine Immunol. , vol.15 , pp. 946-953
    • Omland, K.S.1    Brys, A.2    Lansky, D.3    Clement, K.4    Lynn, F.5
  • 21
    • 29644438356 scopus 로고    scopus 로고
    • Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen
    • Peachman, K. K., M. Rao, C. R. Alving, R. Burge, S. H. Leppla, V. B. Rao, and G. R. Matyas. 2006. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen. Infect. Immun. 74:794-797.
    • (2006) Infect. Immun. , vol.74 , pp. 794-797
    • Peachman, K.K.1    Rao, M.2    Alving, C.R.3    Burge, R.4    Leppla, S.H.5    Rao, V.B.6    Matyas, G.R.7
  • 27
    • 0037493019 scopus 로고    scopus 로고
    • Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough
    • Soelaiman, S., B. Q. Wei, P. Bergson, Y. S. Lee, Y. Shen, M. Mrksich, B. K. Shoichet, and W. J. Tang. 2003. Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J. Biol. Chem. 278:25990-25997.
    • (2003) J. Biol. Chem. , vol.278 , pp. 25990-25997
    • Soelaiman, S.1    Wei, B.Q.2    Bergson, P.3    Lee, Y.S.4    Shen, Y.5    Mrksich, M.6    Shoichet, B.K.7    Tang, W.J.8
  • 29
    • 0018291288 scopus 로고
    • Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors
    • Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580-596.
    • (1979) J. Exp. Med. , vol.150 , pp. 580-596
    • Unkeless, J.C.1
  • 31
    • 70349655887 scopus 로고    scopus 로고
    • Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays
    • Verma, A., M. M. Ngundi, B. D. Meade, R. De Pascalis, K. L. Elkins, and D. L. Burns. 2009. Analysis of the Fc gamma receptor-dependent component of neutralization measured by anthrax toxin neutralization assays. Clin. Vaccine Immunol. 16:1405-1412.
    • (2009) Clin. Vaccine Immunol. , vol.16 , pp. 1405-1412
    • Verma, A.1    Ngundi, M.M.2    Meade, B.D.3    De Pascalis, R.4    Elkins, K.L.5    Burns, D.L.6
  • 32
    • 33749244808 scopus 로고    scopus 로고
    • Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity
    • Vitale, L., D. Blanset, I. Lowy, T. O'Neill, J. Goldstein, S. Little, G. P. Andrews, G. Dorough, R. K. Taylor, and T. Keler. 2006. Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Infect. Immun. 74:5840-5847.
    • (2006) Infect. Immun. , vol.74 , pp. 5840-5847
    • Vitale, L.1    Blanset, D.2    Lowy, I.3    O'Neill, T.4    Goldstein, J.5    Little, S.6    Andrews, G.P.7    Dorough, G.8    Taylor, R.K.9    Keler, T.10
  • 33
    • 29644440248 scopus 로고    scopus 로고
    • Immunological correlates of protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits
    • Weiss, S., D. Kobiler, H. Levy, H. Marcus, A. Pass, N. Rothschild, and Z. Altboum. 2006. Immunological correlates of protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits. Infect. Immun. 74:394-398.
    • (2006) Infect. Immun. , vol.74 , pp. 394-398
    • Weiss, S.1    Kobiler, D.2    Levy, H.3    Marcus, H.4    Pass, A.5    Rothschild, N.6    Altboum, Z.7
  • 34
    • 0034969908 scopus 로고    scopus 로고
    • The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores
    • Welkos, S., S. Little, A. Friedlander, D. Fritz, and P. Fellows. 2001. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147(Pt 6):1677-1685.
    • (2001) Microbiology , vol.147 , Issue.PART 6 , pp. 1677-1685
    • Welkos, S.1    Little, S.2    Friedlander, A.3    Fritz, D.4    Fellows, P.5
  • 35
    • 0031743296 scopus 로고    scopus 로고
    • The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation
    • Zaucha, G. M., M. L. Pitt, J. Estep, B. E. Ivins, and A. M. Friedlander. 1998. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch. Pathol. Lab. Med. 122:982-992.
    • (1998) Arch. Pathol. Lab. Med. , vol.122 , pp. 982-992
    • Zaucha, G.M.1    Pitt, M.L.2    Estep, J.3    Ivins, B.E.4    Friedlander, A.M.5
  • 36
    • 17444391252 scopus 로고    scopus 로고
    • Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen
    • Zmuda, J. F., L. Zhang, T. Richards, Q. Pham, D. Zukauskas, J. L. Pierre, M. W. Laird, J. Askins, and G. H. Choi. 2005. Development of an edema factor-mediated cAMP-induction bioassay for detecting antibody-mediated neutralization of anthrax protective antigen. J. Immunol. Methods 298:47-60.
    • (2005) J. Immunol. Methods , vol.298 , pp. 47-60
    • Zmuda, J.F.1    Zhang, L.2    Richards, T.3    Pham, Q.4    Zukauskas, D.5    Pierre, J.L.6    Laird, M.W.7    Askins, J.8    Choi, G.H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.